Home / Companies / Royalty Pharma Plc / 12 May 2025
Royalty Pharma Plc: meeting of 12 May 2025
Votes reported on Form N-PX, item by item
612 Form N-PX filers reported votes at the Royalty Pharma Plc meeting of 12 May 2025. Their records fall into 8 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
9 nominees; 94.1% of reported votes for; 38 filers withheld from or voted against at least one nominee.
3,756 vote records from 178 filers. 3 of the 178 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
1,134 vote records from 604 filers. 142 of the 575 filers that marked the item either way voted against management. 29 filers reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on pay tied to a merger or sale
941 vote records from 599 filers. 37 of the 570 filers that marked the item either way voted against management. 29 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
1,256 vote records from 178 filers. 1 of the 178 filers that marked the item either way voted against management.
EXTRAORDINARY TRANSACTIONSIssuer
EXTRAORDINARY TRANSACTIONS: management items
Management items in this category are shown together; filers word and number them differently.
413 vote records from 174 filers. 0 of the 174 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
1,258 vote records from 177 filers. 2 of the 177 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
1,225 vote records from 185 filers. 28 of the 185 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
783 vote records from 175 filers. 1 of the 175 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Merger pay | 4. Auditor |
|---|---|---|---|---|
| Vanguard | For | For | For | For |
| BlackRock and iShares | For | For | For | For |
| Fidelity | For | For | For | For |
| Dimensional | For | Against * | For | For |
| State Street and SPDR | For | For | For | For |
| American Century | For | For | Against * | For |
| Franklin Templeton | For | Against * | For | For |
| Invesco | For | For | For | For |
| Equitable | For | For | For | For |
| Charles Schwab | For | For | For | For |
| Nuveen and TIAA | For | For | For | For |
| ProShares and ProFunds | For | For | For | For |
| John Hancock and Manulife | Against * | For | For | For |
| Morgan Stanley, Eaton Vance and Calvert | For | For | For | For |
| J.P. Morgan | For | For | For | For |
| Goldman Sachs | For | For | For | For |
| PGIM and Prudential | For | Against * | For | For |
| Jackson National funds | For | For | For | For |
| Northern Trust and FlexShares | For | For | For | For |
| SEI | For | Against * | For | For |
| T. Rowe Price | For | For | Against * | For |
| Thrivent | For | For | For | For |
| Voya | For | For | Against * | For |
| First Trust | For | For | For | For |
| Russell Investments | For | Against * | For | For |
| Victory Capital | For | For | For | For |
| Brighthouse Funds | For | For | For | For |
| Guggenheim and Rydex | For | For | For | For |
| Columbia Threadneedle | No report | For | For | No report |
| BNY Mellon | For | For | For | For |
| Principal | For | Against * | For | For |
| Capital Group and American Funds | For | For | For | For |
| Pacific Life funds | For | For | For | For |
| Global X | For | Against * | For | For |
| Transamerica | For | For | For | For |
| Federated Hermes | For | For | For | For |
| AllianceBernstein | For | For | For | For |
| DWS | No report | For | For | No report |
| PIMCO | For | For | For | For |
| Allspring | No report | For | For | No report |
| MassMutual | No report | For | For | No report |
| Harbor Funds | For | Against * | For | For |
| VanEck | For | Against * | For | For |
| Macquarie and Delaware Funds | For | For | For | For |
| Janus Henderson | No report | For | For | No report |
| Neuberger Berman | No report | Against * | For | No report |
| Natixis and Loomis Sayles | No report | Against * | For | No report |
| Baird | No report | For | For | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Royalty Pharma Plc meeting?
612 Form N-PX filers reported votes at the meeting of 12 May 2025. On say-on-pay, 142 of 575 voted against management (24.7%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Royalty Pharma Plc on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Royalty Pharma Plc
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Royalty Pharma Plc with a meeting date within three days of 12 May 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.